Muscular dystrophy: Cancer drug may boost muscle strength fo
Study leader Dr. Robert Knight - of the Craniofacial Development and Stem Cell Biology Division at King's College London's Dental Institute in the United Kingdom - and colleagues suggest the cancer drug sunitinib may improve muscle weakness in patients with facioscapulohumeral dystrophy (FSHD).

The researchers recently published their findings in the journal eLife.

FSHD is a form of muscular dystrophy characterized by muscle weakness and wasting, most commonly in the face, shoulders, and upper arms, though it can also affect the pelvis, hips, and lower legs....